SMAD4 and cancer: Confirmation that TM-NGS quantifies the alleles affected, permitting the description of cancer subclonal composition was obtained by immunohistochemistry: this showed that p53 accumulation or Smad4 loss were seen in a proportion of cells comparable to that indicated by the allelic frequency of the mutation in the corresponding gene.